mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.07 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.08 |